Compare ETON & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETON | ATLC |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | 576 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.7M | 797.4M |
| IPO Year | 2018 | N/A |
| Metric | ETON | ATLC |
|---|---|---|
| Price | $25.88 | $66.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $39.33 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 468.4K | 53.3K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | $477.21 |
| Revenue Next Year | $47.23 | $10.42 |
| P/E Ratio | ★ N/A | $9.74 |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.09 | $45.74 |
| 52 Week High | $27.19 | $78.91 |
| Indicator | ETON | ATLC |
|---|---|---|
| Relative Strength Index (RSI) | 68.66 | 73.16 |
| Support Level | $16.79 | $64.75 |
| Resistance Level | N/A | $70.95 |
| Average True Range (ATR) | 1.31 | 2.80 |
| MACD | 0.10 | 1.49 |
| Stochastic Oscillator | 73.61 | 96.72 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.